Hima Doppalapudi, MD
Nephrology · Cedar Rapids, IANPI 1154975928
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $934 of the $1,282 with a category attached, or 72.8%. 11 manufacturers reported payments, led by Vantive US Healthcare LLC at 39.0% of the total. 2025 is the largest year on record at $807, 6.6 times the $123 reported in 2019.
Across 22 payments — averaging $58.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vantive US Healthcare LLC$499
- Johnson & Johnson$163
- AstraZeneca$128
- Amgen$125
- Akebia Therapeutics Inc$125
- Regeneron Healthcare Solutions, Inc.$104
- plus $137 from 5 others
What the payments were for
- Travel & lodging$34827%
- Food & beverage$93473%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vantive US Healthcare LLC | 8 | $499 |
| Johnson & Johnson | 5 | $163 |
| AstraZeneca | 1 | $128 |
| Amgen | 1 | $125 |
| Akebia Therapeutics Inc | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $104 |
| Novo Nordisk | 1 | $58 |
| Actelion Pharmaceuticals US, Inc. | 1 | $33 |
| Fidia Pharma USA Inc. | 1 | $19 |
| AbbVie | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,282 in reported general payments places this provider in the 80th percentile of 73 nephrology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 23 | $23,260 |
| Chlorthalidone | 29 | $561 |
| Lisinopril | 31 | $285 |
| Calcitriol | 19 | $197 |
| Losartan Potassium | 23 | $94 |
| Amlodipine Besylate | 27 | $89 |
| Furosemide | 11 | $64 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Cedar Rapids
- Anwar AhmedCedar Rapids$225
- Paramesh RamaduguCedar Rapids$107
- Abha SaxenaCedar Rapids$104
- Jason CogdillCedar Rapids$25
- Craig ShadurDes Moines$314K
- Andrew BlandDubuque$76K
- Lawrence HunsickerIowa City$70K
- Ashar LuqmanSioux City$56K
- Jeremy PepinCouncil Bluffs$42K
- Prem ChandranDes Moines$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.